The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity

Biochemistry, Genetics and Molecular Biology

• Haplotype 100%
• Human Immunodeficiency Virus 1 100%
• Virion 100%
• Antiviral Activity 100%
• Virus Nucleocapsid 37%
• Protein Expression 25%
• Enzymatic Activity 25%
• Enzyme 12%
• Retrovirus 12%
• Reverse Transcription 12%
• N-Terminus 12%
• RNA 12%
• C-Terminus 12%
• Escherichia coli 12%
• Amino Acids 12%
• Capsid 12%
• Deletion Mutant 12%
• Cytidine Deaminase 12%
• Virus Core 12%

Immunology and Microbiology

• Virion 100%
• Human Immunodeficiency Virus 1 100%
• Haplotype 100%
• Antiviral Activity 100%
• Virus Nucleocapsid 37%
• Protein Expression 25%
• Retrovirus 12%
• Reverse Transcription 12%
• Amino Terminal Sequence 12%
• Carboxy Terminal Sequence 12%
• Escherichia coli 12%
• Capsid 12%
• Deletion Mutant 12%
• Virus Core 12%
• Amino Acid 12%
• Ribonucleic Acid 12%

Keyphrases

• Virion 100%
• Human Immunodeficiency Virus Type 1 (HIV-1) 100%
• Antiviral Activity 100%
• APOBEC3H 100%
• Protein Expression 11%
• Virion Incorporation 11%
• APOBEC3 5%
• Retrovirus 5%
• Reverse Transcription 5%
• Catalytic Activity 5%
• Escherichia Coli 5%
• Deletion mutant 5%
• Single Domain 5%
• Amino Acid Position 5%
• Mutator 5%
• Antiviral Potential 5%
• Capsid 5%
• Transcription Complex 5%
• Cytidine Deaminase 5%
• Viral Core 5%
• Site-directed mutant 5%
• Incorporation Efficiency 5%
• RNA-dependent 5%
• Enzymatic Efficiency 5%
• Cellular Expression 5%
• Enzyme-catalyzed 5%